Home Business Stocks To Watch: SunPower, Gap, Family Dollar, Mellanox, Biogen Idec

Stocks To Watch: SunPower, Gap, Family Dollar, Mellanox, Biogen Idec

Advertisement Disclosure: When you purchase through our sponsored links, we may earn a commission from our partners. By using this website you agree to our T&Cs.

Companies whose stocks are expected to trade actively in today’s session are SunPower Corporation (NASDAQ:SPWR), The Gap Inc. (NYSE:GPS), Family Dollar Stores, Inc. (NYSE:FDO), Mellanox Technologies, Ltd. (NASDAQ:MLNX) and Biogen Idec Inc. (NASDAQ:BIIB).

Stocks To Watch: SunPower, Gap, Family Dollar, Mellanox, Biogen Idec

SunPower Corporation (NASDAQ:SPWR): The solar power company’s shares surged 26.26 percent to $7.73, after Lazard raised its ratings for SunPower to buy from neutral with $11 price target. Lazard said the stock has a strong sales visibility and it may become a highly competitive company in the solar market. On Wednesday, the company sold its stake in California solar project to MidAmerican Renewables.

The Gap Inc. (NYSE:GPS): The specialty apparel company announced that its same-store sales in December rose 5 percent, compared to analysts’ estimate of 3.5 percent gain. The company has also approved a share buyback program worth $1 billion. Shares initially surged 5.2 percent in premarket trading, but were almost flat in early market trading.

Family Dollar Stores, Inc. (NYSE:FDO): The discount retailer reported a lower than estimated first quarter earnings. CEO Howard Levine said that the holiday selling season was much more challenging than expected. Family Dollar has also reduced its full-year earnings forecasts. Shares plunged 11 percent to $56.93.

Mellanox Technologies, Ltd. (NASDAQ:MLNX): The data storage company is going through a rough patch as its sales continue to decline. Mellanox has substantially reduced its fourth quarter sales estimates due to weakening demand. Shares were down 16 percent to $51.43 in early market trading.

Biogen Idec Inc. (NASDAQ:BIIB): The biopharmaceutical firm said that its molecule for Lou Gehrig’s disease failed to meet its primary goals in Phase 3 clinical trials. So the company will have to discontinue work on this drug. Shares were down 3.5 percent to $144.89.

Another company to watch out today is CIT Group Inc. (NYSE:CIT). In an attempt to boost its market share in lending to the midsize businesses, the company is acquiring commercial loan portfolio of Flagstar Bancorp Inc (NYSE:FBC) for $779 million.

Our Editorial Standards

At ValueWalk, we’re committed to providing accurate, research-backed information. Our editors go above and beyond to ensure our content is trustworthy and transparent.

Editor
Investing

Which Stocks Should You Buy, and Sell, in 2026?

Dave Kovaleski6 months

Also, the 3 sectors that Wall Street analysts are most bullish about. The usual suspects dominated in 2025 as both the Communication Services and Information Technology sectors helped boost the...